InsidersTradesSigma
Track the 睿昂基因 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 睿昂基因 has recorded 2 insider filings. Market capitalisation: €1.1bn. The latest transaction was reported on 12 September 2023 (Sale). Among the most active insiders: 柯中和. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
睿昂基因 is a company focused on the health and pharmaceutical sector, specializing in the development of innovative genetic solutions. It is listed on the Shanghai Stock Exchange.